-
1
-
-
58949083350
-
Incidence of endophthal mitisrelated to intravitreal injection of bevacizumab and ranibizumab
-
Fintak DR, Gaurav KS, Blinder KJ, et al. Incidence of endophthal mitisrelated to intravitreal injection of bevacizumab and ranibizumab. Retina.2008;28:1395-1399.
-
(2008)
Retina
, vol.28
, pp. 1395-1399
-
-
Fintak, D.R.1
Gaurav, K.S.2
Blinder, K.J.3
-
2
-
-
63249134493
-
Increased incidence of sterileendophthalmitis after intravitreal triamcinolone acetonide in spring2006
-
Stepien KE, Eaton AM, Jaffe GJ, et al. Increased incidence of sterileendophthalmitis after intravitreal triamcinolone acetonide in spring2006. Retina. 2009;29:207-213.
-
(2009)
Retina
, vol.29
, pp. 207-213
-
-
Stepien, K.E.1
Eaton, A.M.2
Jaffe, G.J.3
-
3
-
-
23044505200
-
Optical coherencetomography findings after an intravitreal injection of bevacizumab(Avastin) for neovascular age-related macular degeneration
-
Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherencetomography findings after an intravitreal injection of bevacizumab(Avastin) for neovascular age-related macular degeneration. OphthalmicSurg Lasers Imaging. 2005;36:331-335.
-
(2005)
OphthalmicSurg Lasers Imaging
, vol.36
, pp. 331-335
-
-
Rosenfeld, P.J.1
Moshfeghi, A.A.2
Puliafito, C.A.3
-
4
-
-
0036161392
-
Intravitrealtriamcinolone for the treatment of macular oedema due to central retinalvein occlusion
-
Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitrealtriamcinolone for the treatment of macular oedema due to central retinalvein occlusion. Br J Ophthalmol. 2002;86:247-248.
-
(2002)
Br J Ophthalmol
, vol.86
, pp. 247-248
-
-
Greenberg, P.B.1
Martidis, A.2
Rogers, A.H.3
Duker, J.S.4
Reichel, E.5
-
5
-
-
33645641520
-
Ranibizumab for treatmentof neovascular age-related macular degeneration: A phase I/II multicenter,controlled, multidose study
-
Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatmentof neovascular age-related macular degeneration: a phase I/II multicenter,controlled, multidose study. Ophthalmology. 2006;113:633-642.
-
(2006)
Ophthalmology
, vol.113
, pp. 633-642
-
-
Heier, J.S.1
Antoszyk, A.N.2
Pavan, P.R.3
-
7
-
-
42549140659
-
Incidence of acute onsetendophthalmitis following intravitreal bevacizumab (Avastin) injection
-
Mason JO, Milton FW, Feist RM, et al. Incidence of acute onsetendophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina. 2008;28:564-567.
-
(2008)
Retina
, vol.28
, pp. 564-567
-
-
Mason, J.O.1
Milton, F.W.2
Feist, R.M.3
-
9
-
-
73349107165
-
Risk of endophthalmitisafter intravitreal drug injection when topical antibiotics are not required
-
Bhavsar AR, Googe JM, Stockdale CR, et al. Risk of endophthalmitisafter intravitreal drug injection when topical antibiotics are not required. Arch Ophthalmology. 2009;127:1581-1583.
-
(2009)
Arch Ophthalmology
, vol.127
, pp. 1581-1583
-
-
Bhavsar, A.R.1
Googe, J.M.2
Stockdale, C.R.3
-
10
-
-
66349109710
-
Pach JM.Infectious endophthalmitis after intravitral injection of antiangiogenicagents
-
Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM.Infectious endophthalmitis after intravitral injection of antiangiogenicagents. Retina. 2009;29:601-60511.
-
(2009)
Retina
, vol.29
, pp. 601-60511
-
-
Diago, T.1
McCannel, C.A.2
Bakri, S.J.3
Pulido, J.S.4
Edwards, A.O.5
-
11
-
-
11144239923
-
Pegaptanib forneovascular age-related macular degeneration
-
Gragoudas ES, Adamis AP, Cunningham ET, et al. Pegaptanib forneovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
-
(2004)
N Engl J Med
, vol.351
, pp. 2805-2816
-
-
Gragoudas, E.S.1
Adamis, A.P.2
Cunningham, E.T.3
-
12
-
-
34250902347
-
Infectiousand noninfectious endophthalmitis after intravitreal bevacizumab
-
Jonas JB, Spandau UH, Rensch F, Von Baltz S, Schlichtenbrede F. Infectiousand noninfectious endophthalmitis after intravitreal bevacizumab.J Ocul Pharmacol Ther. 2007;23:240-242.
-
(2007)
J Ocul Pharmacol Ther
, vol.23
, pp. 240-242
-
-
Jonas, J.B.1
Spandau, U.H.2
Rensch, F.3
von Baltz, S.4
Schlichtenbrede, F.5
-
13
-
-
68949120403
-
Bahcecioglu H.Incidence and management of acute endophthalmitis after intravitrealbevacizumab (Avastin) injection
-
Artunay O, Yuzbasioglu E, Rasier R, Sengül A, Bahcecioglu H.Incidence and management of acute endophthalmitis after intravitrealbevacizumab (Avastin) injection. Eye. 2009;23:2187-2193.
-
(2009)
Eye
, vol.23
, pp. 2187-2193
-
-
Artunay, O.1
Yuzbasioglu, E.2
Rasier, R.3
Sengül, A.4
-
14
-
-
33749445317
-
Ranibizumab for neovascularage-related macular degeneration
-
Rosenfeld PJ, Brown MD, Heier JS, et al. Ranibizumab for neovascularage-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
-
(2006)
N Engl J Med
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, M.D.2
Heier, J.S.3
-
15
-
-
33144475205
-
Infectious and noninfectiousendophthalmitis after intravitreal high-dosage triamcinoloneacetonide
-
Jonas JB, Kreissing I, Spandau UH, Harder B. Infectious and noninfectiousendophthalmitis after intravitreal high-dosage triamcinoloneacetonide.Am J Ophthalmol. 2006;141:579-580.
-
(2006)
Am J Ophthalmol
, vol.141
, pp. 579-580
-
-
Jonas, J.B.1
Kreissing, I.2
Spandau, U.H.3
Harder, B.4
-
16
-
-
49749086517
-
Distinguishing between infectious and noninfectiousendophthalmitis after intravitreal triamcinolone injection
-
Roth DB, Flynn HW. Distinguishing between infectious and noninfectiousendophthalmitis after intravitreal triamcinolone injection.Am J Ophthalmol. 2008;146:346-347.
-
(2008)
Am J Ophthalmol
, vol.146
, pp. 346-347
-
-
Roth, D.B.1
Flynn, H.W.2
-
17
-
-
0025779878
-
The Endophthalmitis Vitrectomy Study
-
Doft BH. The Endophthalmitis Vitrectomy Study. Arch Ophthalmol.1991;109:487-489.
-
(1991)
Arch Ophthalmol
, vol.109
, pp. 487-489
-
-
Doft, B.H.1
-
18
-
-
42249110488
-
Legacy of the Vitrectomy Study
-
Flynn HW, Scott IU. Legacy of the Vitrectomy Study. Arch Ophthalmol.2008;126:559-561.
-
(2008)
Arch Ophthalmol
, vol.126
, pp. 559-561
-
-
Flynn, H.W.1
Scott, I.U.2
-
19
-
-
38049186578
-
Endophthalmitis after 25-gaugeand 20-gauge pars plana vitrectomy: Incidence and outcomes
-
Scott IU, Flynn HW, Sundeep D, et al. Endophthalmitis after 25-gaugeand 20-gauge pars plana vitrectomy: incidence and outcomes. Retina.2008;28:138-142.
-
(2008)
Retina
, vol.28
, pp. 138-142
-
-
Scott, I.U.1
Flynn, H.W.2
Sundeep, D.3
-
21
-
-
0026344747
-
Prophylaxis of endophthalmitis withpovidone-iodine
-
Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis withpovidone-iodine. Ophthalmology. 1991;98:1769-1775.
-
(1991)
Ophthalmology
, vol.98
, pp. 1769-1775
-
-
Speaker, M.G.1
Menikoff, J.A.2
-
22
-
-
34447508448
-
The role of topical antibiotic prophylaxis forintravitreal injections
-
Scott IU, Flynn HW. The role of topical antibiotic prophylaxis forintravitreal injections. Arch Ophthalmol. 2007;125:974-976.
-
(2007)
Arch Ophthalmol
, vol.125
, pp. 974-976
-
-
Scott, I.U.1
Flynn, H.W.2
|